Pseudomonas aeruginosa infection: pathogenesis and therapy.
D001428:Bacterial Vaccines / Q000627:therapeutic use; D002056:Burns / Q000150:complications; D002228:Carbenicillin / Q000627:therapeutic use; D003428:Cross Infection / Q000209:etiology; D003550:Cystic Fibrosis / Q000150:complications; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D011552:Pseudomonas Infections / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D011550:Pseudomonas aeruginosa / Q000276:immunology; D013982:Ticarcillin / Q000627:therapeutic use; D014031:Tobramycin / Q000627:therapeutic use; D014946:Wound Infection / Q000209:etiology
D001428:Bacterial Vaccines; D005839:Gentamicins; D013982:Ticarcillin; D002228:Carbenicillin; D014031:Tobramycin